" /> Tipapkinogene Sovacivec - CISMeF





Preferred Label : Tipapkinogene Sovacivec;

NCIt synonyms : MVA-HPV16E6/E7-IL2; MVA-HPV-IL2; HPV16 E6/E7-encoding MVA Vaccine TG4001;

NCIt definition : A cancer vaccine comprised of a modified, replication-defective, vaccinia virus Ankara (MVA) strain encoding the tumor-associated antigens (TAAs) human papillomavirus type 16 (HPV16) subtypes E6 and E7, and human interleukin-2 (IL-2), with potential immunostimulating and antineoplastic activities. Vaccination with tipapkinogene sovacivec stimulates the host immune system to mount a cytotoxic T-lymphocyte (CTL) response against tumor cells expressing HPV16 E6 and E7, resulting in tumor cell lysis. Expression of IL-2 augments the specific CTL response against HPV16 E6- and E7-expressing tumor cells.;

UNII : P34L5Y2SR5;

CAS number : 1052105-48-2; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 1052105-48-2 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Molecule name : RO5217790; TG 4001; R3484; RG3484; TG-4001;

NCI Metathesaurus CUI : CL413588;

Details


You can consult :


Nous contacter.
16/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.